Table 2.

Characteristics of Tuberculosis (n = 158)

Variables	Frequency	Percentage
TB site  Pulmonary  Extrapulmonary	137 21	86.7 13.3
Extrapulmonary site (n = 21)  Spine  Lymphadenitis  Meningitis  Abdomen  Bone	13 3 3 1 1	61.9 14.3 14.3 4.8 4.8
Previous TB treatment  Yes  No	14 144	8.9 91.1
Status of previous treatment (n = 14)  Completed  Interrupted	5 9	35.7 64.3
Drug resistance  Yes  No	27 131	17.1 82.9
Names of drug (n = 27)  Streptomycin  Isoniazid  Ethambutol  Rifampicin  Streptomycin–isoniazid  Streptomycin–rifampicin  Rifampicin–isoniazid  Streptomycin–isoniazid–ethambutol  Rifampicin–isoniazid–ethambutol  Rifampicin–isoniazid–ethambutol–streptomycin  Rifampicin–isoniazid–ethambutol–pyrazinamide  Rifampicin–isoniazid–ethambutol–streptomycin–pyrazinamide	7 3 2 2 2 2 2 1 1 2 1 2	25.9 11.1 7.4 7.4 7.4 7.4 7.4 3.7 3.7 7.4 3.7 7.4
Resistance class (n = 27)  MDR  Mono  Rifampicinesistant  Polyresistant	8 12 2 5	29.6 44.4 7.4 18.5